Luis Nunez
Research Associate
Also affiliated: Cegep de Saint Hyacinthe (1994); The University of Texas Health Science Center at Houston (2022–2023)
Postdoc Researcher
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Luis Nunez's research focuses on medical imaging and neurological disorders, with a specific emphasis on brain tumors and spinal injuries. He has investigated the diagnostic value of apparent diffusion coefficient (ADC) values in differentiating glioblastoma progression from treatment-related changes and explored the predictive utility of standard-of-care MRI for determining MGMT promoter methylation status in IDH wild-type glioblastoma. Nunez has also examined imaging findings in pediatric epilepsy, including the "Temporal Thumb Sign," and contributed to the understanding of neuro-ocular syndrome associated with spaceflight. His work extends to the characterization of acute spinal injuries in athletes, specifically in American football, and the imaging of both common and infrequent extradural tumors. Nunez's scholarship includes 8 publications, with a total of 53 citations and an h-index of 3.
Metrics
- h-index: 3
- Publications: 8
- Citations: 55
Selected Publications
-
IDH wild-type glioblastoma: Predictive value of standard-of-care (SOC) MRI for establishing MGMT promoter methylation status (2025)
-
Glioblastoma IDH-wild type: imaging independent predictors of gross total resection (GTR) using the VASARI feature set and tumoral volumetric measurements (2025)
Collaboration Network
Top Collaborators
- Glioblastoma IDH-wild type: imaging independent predictors of gross total resection (GTR) using the VASARI feature set and tumoral volumetric measurements
- IDH wild-type glioblastoma: Predictive value of standard-of-care (SOC) MRI for establishing MGMT promoter methylation status
- Glioblastoma IDH-wild type: imaging independent predictors of gross total resection (GTR) using the VASARI feature set and tumoral volumetric measurements
- IDH wild-type glioblastoma: Predictive value of standard-of-care (SOC) MRI for establishing MGMT promoter methylation status
- Glioblastoma IDH-wild type: imaging independent predictors of gross total resection (GTR) using the VASARI feature set and tumoral volumetric measurements
- IDH wild-type glioblastoma: Predictive value of standard-of-care (SOC) MRI for establishing MGMT promoter methylation status
- Glioblastoma IDH-wild type: imaging independent predictors of gross total resection (GTR) using the VASARI feature set and tumoral volumetric measurements
- IDH wild-type glioblastoma: Predictive value of standard-of-care (SOC) MRI for establishing MGMT promoter methylation status
- Glioblastoma IDH-wild type: imaging independent predictors of gross total resection (GTR) using the VASARI feature set and tumoral volumetric measurements
- IDH wild-type glioblastoma: Predictive value of standard-of-care (SOC) MRI for establishing MGMT promoter methylation status
- Glioblastoma IDH-wild type: imaging independent predictors of gross total resection (GTR) using the VASARI feature set and tumoral volumetric measurements
- IDH wild-type glioblastoma: Predictive value of standard-of-care (SOC) MRI for establishing MGMT promoter methylation status
- Glioblastoma IDH-wild type: imaging independent predictors of gross total resection (GTR) using the VASARI feature set and tumoral volumetric measurements
- IDH wild-type glioblastoma: Predictive value of standard-of-care (SOC) MRI for establishing MGMT promoter methylation status
- Glioblastoma IDH-wild type: imaging independent predictors of gross total resection (GTR) using the VASARI feature set and tumoral volumetric measurements
- Glioblastoma IDH-wild type: imaging independent predictors of gross total resection (GTR) using the VASARI feature set and tumoral volumetric measurements
- IDH wild-type glioblastoma: Predictive value of standard-of-care (SOC) MRI for establishing MGMT promoter methylation status
- IDH wild-type glioblastoma: Predictive value of standard-of-care (SOC) MRI for establishing MGMT promoter methylation status
Similar Researchers
Based on overlapping research topics